Juncker seen making U-turn on medicines policy

EurActiv reported on 10 October 2014 that European Commission president Jean-Claude Juncker had ceded to pressure from MEPs and abandoned his plan to return control of medicines and pharmaceutical products to the Industry Commissioner.

This responsibility was set instead to remain in the hands of the Health Commissioner.

• Primary Source

ESO: Background information: Pharma industry denies it lobbied for medicines to move to DG Enterprise http://www.europeansources.info/record/pharma-industry-denies-it-lobbied-for-medicines-to-move-to-dg-enterprise/

---